Literature DB >> 1306703

Single-center experience of unrelated living-donor renal transplantation in the cyclosporine era.

K Park1, Y S Kim, E M Lee, H Y Lee, D S Han.   

Abstract

Renal transplantation from the unrelated living-donor might be an alternative when the cadaveric or related donor is not available, because graft and patient survival rates are superior to those of kidneys from cadaveric donors and even comparable to those from related donors. Among the many factors that might contribute to these excellent results, we believe that the good quality of kidneys (lacking preservation or ischemic injury) is the most important one. In addition, our criteria for patient selection requiring well-matched HLA typing might partially contribute to our success. For the successful renal transplantation program using unrelated-living donors, high ethical standards, accumulated experience from living-related donor transplantation, and dedicated professionalism are strongly recommended.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306703

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  4 in total

Review 1.  Pediatric kidney transplantation: a historical review.

Authors:  Priya S Verghese
Journal:  Pediatr Res       Date:  2016-10-12       Impact factor: 3.756

2.  2,500 living donor kidney transplants: a single-center experience.

Authors:  A J Matas; W D Payne; D E Sutherland; A Humar; R W Gruessner; R Kandaswamy; D L Dunn; K J Gillingham; J S Najarian
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

3.  Media appeals by pediatric patients for living donors and the impact on a transplant center.

Authors:  Priya S Verghese; Catherine A Garvey; Michael S Mauer; Arthur J Matas
Journal:  Transplantation       Date:  2011-03-27       Impact factor: 4.939

4.  Complications in 100 living-liver donors.

Authors:  H P Grewal; J R Thistlewaite; G E Loss; J S Fisher; D C Cronin; C T Siegel; K A Newell; D S Bruce; E S Woodle; L Brady; S Kelly; P Boone; K Oswald; J M Millis
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.